Cargando…

172. Risk Factors for 30-Day Mortality in Patients with Staphylococcus aureus Bacteremia at a Community Hospital: A Prospective Case–Control Study

BACKGROUND: Staphylococcus aureus bacteremia (SAB) is associated with 30-day all-cause mortality rates approaching 20–30%. The purpose of this case–control study was to evaluate risk factors for 30-day mortality in patients with SAB at a community hospital. METHODS: As part of an antimicrobial stewa...

Descripción completa

Detalles Bibliográficos
Autores principales: Hoffmann, Charles, Watkins, Gordon, DeSimone, Patrick, Hallisey, Peter, Hutchinson, David, Colodny, Stephen, Burket, Jeffrey, Michael, Amanda, Klein, Jo-anne, Welc, Christina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810170/
http://dx.doi.org/10.1093/ofid/ofz360.247
_version_ 1783462183827406848
author Hoffmann, Charles
Watkins, Gordon
DeSimone, Patrick
Hallisey, Peter
Hutchinson, David
Colodny, Stephen
Burket, Jeffrey
Michael, Amanda
Klein, Jo-anne
Welc, Christina
author_facet Hoffmann, Charles
Watkins, Gordon
DeSimone, Patrick
Hallisey, Peter
Hutchinson, David
Colodny, Stephen
Burket, Jeffrey
Michael, Amanda
Klein, Jo-anne
Welc, Christina
author_sort Hoffmann, Charles
collection PubMed
description BACKGROUND: Staphylococcus aureus bacteremia (SAB) is associated with 30-day all-cause mortality rates approaching 20–30%. The purpose of this case–control study was to evaluate risk factors for 30-day mortality in patients with SAB at a community hospital. METHODS: As part of an antimicrobial stewardship program (ASP) initiative mandating Infectious Diseases consultation for episodes of SAB, our ASP prospectively monitored all cases of SAB at a 341-bed community hospital in Jefferson Hills, PA from April 2017–February 2019. Cases included patients with 30-day mortality from the initial positive blood culture. Only the first episode of SAB was included; patients were excluded if a treatment plan was not established (e.g., left against medical advice). Patient demographics, comorbidities, laboratory results, and clinical management of SAB were evaluated. Inferential statistics were used to analyze risk factors associated with 30-day mortality. RESULTS: 100 patients with SAB were included; 18 (18%) experienced 30-day mortality. Cases were older (median age 76.5 vs. 64 years, P < 0.001), more likely to be located in the intensive care unit (ICU) at time of ASP review (55.6% vs. 30.5%, P = 0.043), and less likely to have initial blood cultures obtained in the emergency department (ED) (38.9% vs. 80.5%, P < 0.001). Variables associated with significantly higher odds for 30-day mortality in univariate analysis: older age, location in ICU at time of ASP review, initial blood cultures obtained at a location other than the ED, and total Charlson Comorbidity Index (CCI). Variables with P < 0.2 on univariate analysis were analyzed via multivariate logistic regression (Table 1). CONCLUSION: Results show that bacteremia due to MRSA and total CCI were not significantly associated with 30-day mortality in SAB, whereas older age was identified as a risk factor. Patients with initial blood cultures obtained at a location other than the ED were at increased odds for 30-day mortality on univariate analysis, which may raise concern for delayed diagnosis. [Image: see text] DISCLOSURES: All authors: No reported disclosures.
format Online
Article
Text
id pubmed-6810170
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-68101702019-10-28 172. Risk Factors for 30-Day Mortality in Patients with Staphylococcus aureus Bacteremia at a Community Hospital: A Prospective Case–Control Study Hoffmann, Charles Watkins, Gordon DeSimone, Patrick Hallisey, Peter Hutchinson, David Colodny, Stephen Burket, Jeffrey Michael, Amanda Klein, Jo-anne Welc, Christina Open Forum Infect Dis Abstracts BACKGROUND: Staphylococcus aureus bacteremia (SAB) is associated with 30-day all-cause mortality rates approaching 20–30%. The purpose of this case–control study was to evaluate risk factors for 30-day mortality in patients with SAB at a community hospital. METHODS: As part of an antimicrobial stewardship program (ASP) initiative mandating Infectious Diseases consultation for episodes of SAB, our ASP prospectively monitored all cases of SAB at a 341-bed community hospital in Jefferson Hills, PA from April 2017–February 2019. Cases included patients with 30-day mortality from the initial positive blood culture. Only the first episode of SAB was included; patients were excluded if a treatment plan was not established (e.g., left against medical advice). Patient demographics, comorbidities, laboratory results, and clinical management of SAB were evaluated. Inferential statistics were used to analyze risk factors associated with 30-day mortality. RESULTS: 100 patients with SAB were included; 18 (18%) experienced 30-day mortality. Cases were older (median age 76.5 vs. 64 years, P < 0.001), more likely to be located in the intensive care unit (ICU) at time of ASP review (55.6% vs. 30.5%, P = 0.043), and less likely to have initial blood cultures obtained in the emergency department (ED) (38.9% vs. 80.5%, P < 0.001). Variables associated with significantly higher odds for 30-day mortality in univariate analysis: older age, location in ICU at time of ASP review, initial blood cultures obtained at a location other than the ED, and total Charlson Comorbidity Index (CCI). Variables with P < 0.2 on univariate analysis were analyzed via multivariate logistic regression (Table 1). CONCLUSION: Results show that bacteremia due to MRSA and total CCI were not significantly associated with 30-day mortality in SAB, whereas older age was identified as a risk factor. Patients with initial blood cultures obtained at a location other than the ED were at increased odds for 30-day mortality on univariate analysis, which may raise concern for delayed diagnosis. [Image: see text] DISCLOSURES: All authors: No reported disclosures. Oxford University Press 2019-10-23 /pmc/articles/PMC6810170/ http://dx.doi.org/10.1093/ofid/ofz360.247 Text en © The Author(s) 2019. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Abstracts
Hoffmann, Charles
Watkins, Gordon
DeSimone, Patrick
Hallisey, Peter
Hutchinson, David
Colodny, Stephen
Burket, Jeffrey
Michael, Amanda
Klein, Jo-anne
Welc, Christina
172. Risk Factors for 30-Day Mortality in Patients with Staphylococcus aureus Bacteremia at a Community Hospital: A Prospective Case–Control Study
title 172. Risk Factors for 30-Day Mortality in Patients with Staphylococcus aureus Bacteremia at a Community Hospital: A Prospective Case–Control Study
title_full 172. Risk Factors for 30-Day Mortality in Patients with Staphylococcus aureus Bacteremia at a Community Hospital: A Prospective Case–Control Study
title_fullStr 172. Risk Factors for 30-Day Mortality in Patients with Staphylococcus aureus Bacteremia at a Community Hospital: A Prospective Case–Control Study
title_full_unstemmed 172. Risk Factors for 30-Day Mortality in Patients with Staphylococcus aureus Bacteremia at a Community Hospital: A Prospective Case–Control Study
title_short 172. Risk Factors for 30-Day Mortality in Patients with Staphylococcus aureus Bacteremia at a Community Hospital: A Prospective Case–Control Study
title_sort 172. risk factors for 30-day mortality in patients with staphylococcus aureus bacteremia at a community hospital: a prospective case–control study
topic Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810170/
http://dx.doi.org/10.1093/ofid/ofz360.247
work_keys_str_mv AT hoffmanncharles 172riskfactorsfor30daymortalityinpatientswithstaphylococcusaureusbacteremiaatacommunityhospitalaprospectivecasecontrolstudy
AT watkinsgordon 172riskfactorsfor30daymortalityinpatientswithstaphylococcusaureusbacteremiaatacommunityhospitalaprospectivecasecontrolstudy
AT desimonepatrick 172riskfactorsfor30daymortalityinpatientswithstaphylococcusaureusbacteremiaatacommunityhospitalaprospectivecasecontrolstudy
AT halliseypeter 172riskfactorsfor30daymortalityinpatientswithstaphylococcusaureusbacteremiaatacommunityhospitalaprospectivecasecontrolstudy
AT hutchinsondavid 172riskfactorsfor30daymortalityinpatientswithstaphylococcusaureusbacteremiaatacommunityhospitalaprospectivecasecontrolstudy
AT colodnystephen 172riskfactorsfor30daymortalityinpatientswithstaphylococcusaureusbacteremiaatacommunityhospitalaprospectivecasecontrolstudy
AT burketjeffrey 172riskfactorsfor30daymortalityinpatientswithstaphylococcusaureusbacteremiaatacommunityhospitalaprospectivecasecontrolstudy
AT michaelamanda 172riskfactorsfor30daymortalityinpatientswithstaphylococcusaureusbacteremiaatacommunityhospitalaprospectivecasecontrolstudy
AT kleinjoanne 172riskfactorsfor30daymortalityinpatientswithstaphylococcusaureusbacteremiaatacommunityhospitalaprospectivecasecontrolstudy
AT welcchristina 172riskfactorsfor30daymortalityinpatientswithstaphylococcusaureusbacteremiaatacommunityhospitalaprospectivecasecontrolstudy